CareDx ROE 2013-2026 | CDNA
Current and historical return on equity (ROE) values for CareDx (CDNA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| CareDx ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2026-06-30 | $0.11B | $0.34B | 33.09% |
| 2026-03-31 | $-0.01B | $0.31B | -2.55% |
| 2025-12-31 | $-0.02B | $0.33B | -6.36% |
| 2025-09-30 | $0.07B | $0.35B | 20.36% |
| 2025-06-30 | $0.06B | $0.34B | 17.10% |
| 2025-03-31 | $0.06B | $0.32B | 19.15% |
| 2024-12-31 | $0.05B | $0.29B | 17.75% |
| 2024-09-30 | $-0.15B | $0.26B | -58.39% |
| 2024-06-30 | $-0.17B | $0.29B | -56.46% |
| 2024-03-31 | $-0.19B | $0.33B | -56.53% |
| 2023-12-31 | $-0.19B | $0.37B | -51.35% |
| 2023-09-30 | $-0.09B | $0.41B | -21.82% |
| 2023-06-30 | $-0.08B | $0.42B | -19.85% |
| 2023-03-31 | $-0.08B | $0.43B | -18.71% |
| 2022-12-31 | $-0.08B | $0.44B | -17.40% |
| 2022-09-30 | $-0.08B | $0.45B | -16.62% |
| 2022-06-30 | $-0.07B | $0.46B | -15.22% |
| 2022-03-31 | $-0.05B | $0.47B | -10.66% |
| 2021-12-31 | $-0.03B | $0.47B | -6.56% |
| 2021-09-30 | $-0.02B | $0.43B | -4.47% |
| 2021-06-30 | $-0.01B | $0.38B | -2.67% |
| 2021-03-31 | $-0.02B | $0.32B | -4.69% |
| 2020-12-31 | $-0.02B | $0.23B | -8.80% |
| 2020-09-30 | $-0.02B | $0.18B | -11.51% |
| 2020-06-30 | $-0.02B | $0.14B | -14.31% |
| 2020-03-31 | $-0.02B | $0.10B | -21.48% |
| 2019-12-31 | $-0.02B | $0.10B | -23.83% |
| 2019-09-30 | $-0.02B | $0.10B | -22.98% |
| 2019-06-30 | $-0.04B | $0.08B | -48.63% |
| 2019-03-31 | $-0.05B | $0.07B | -69.43% |
| 2018-12-31 | $-0.05B | $0.05B | -93.07% |
| 2018-09-30 | $-0.08B | $0.03B | -300.00% |
| 2018-06-30 | $-0.07B | $0.01B | -492.86% |
| 2018-03-31 | $-0.06B | $0.01B | -605.13% |
| 2017-12-31 | $-0.06B | $0.01B | -1066.67% |
| 2017-09-30 | $-0.04B | $0.01B | -331.91% |
| 2017-06-30 | $-0.03B | $0.02B | -138.10% |
| 2017-03-31 | $-0.04B | $0.03B | -133.33% |
| 2016-12-31 | $-0.04B | $0.03B | -141.82% |
| 2016-09-30 | $-0.03B | $0.03B | -97.48% |
| 2016-06-30 | $-0.03B | $0.03B | -96.55% |
| 2016-03-31 | $-0.02B | $0.03B | -70.00% |
| 2015-12-31 | $-0.01B | $0.04B | -37.41% |
| 2015-09-30 | $-0.01B | $0.04B | -21.19% |
| 2015-06-30 | $0.00B | $0.04B | -10.13% |
| 2015-03-31 | $0.00B | $0.03B | 0.00% |
| 2014-12-31 | $0.00B | $0.02B | 6.25% |
| 2014-09-30 | $0.00B | $0.00B | 0.00% |
| 2014-06-30 | $0.00B | $-0.01B | 24.24% |
| 2014-03-31 | $0.00B | $-0.01B | 50.00% |
| 2013-12-31 | $0.00B | $0.00B | 106.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.785B | $0.380B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.899B | 26.08 |
| CVS Health (CVS) | United States | $113.624B | 11.33 |
| HCA Healthcare (HCA) | United States | $92.600B | 14.40 |
| Elevance Health (ELV) | United States | $89.122B | 13.98 |
| Cencora (COR) | United States | $58.924B | 18.00 |
| Natera (NTRA) | United States | $53.245B | 0.00 |
| Labcorp Holdings (LH) | United States | $26.010B | 18.34 |
| Viatris (VTRS) | United States | $19.469B | 6.73 |
| Medpace Holdings (MEDP) | United States | $17.091B | 35.89 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.888B | 0.00 |
| DiDi Global (DIDIY) | China | $16.776B | 184.00 |
| Revvity (RVTY) | United States | $16.007B | 26.81 |
| Solventum (SOLV) | United States | $15.123B | 12.51 |
| Charles River Laboratories (CRL) | United States | $13.274B | 28.09 |
| ICON (ICLR) | Ireland | $12.565B | 17.08 |
| BrightSpring Health Services (BTSG) | United States | $11.235B | 38.63 |
| Avantor (AVTR) | United States | $10.497B | 18.93 |
| BioMerieux (BMXMF) | France | $9.856B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.472B | 83.28 |
| HealthEquity (HQY) | United States | $7.870B | 25.64 |
| Sonic Healthcare (SKHHY) | Australia | $6.732B | 0.00 |
| PACS (PACS) | United States | $6.666B | 22.40 |
| GETINGE (GNGBY) | Sweden | $6.516B | 18.40 |
| CochLear (CHEOY) | Australia | $6.200B | 0.00 |
| MiniMed (MMED) | United States | $6.131B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.021B | 22.77 |
| Sotera Health (SHC) | United States | $5.345B | 22.03 |
| Concentras Parent (CON) | United States | $4.523B | 22.31 |
| Organon (OGN) | United States | $3.593B | 4.56 |
| GeneDx Holdings (WGS) | United States | $3.015B | 280.83 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.107B | 12.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.103B | 0.00 |
| Progyny (PGNY) | United States | $2.082B | 29.49 |
| Establishment Labs Holdings (ESTA) | United States | $2.065B | 0.00 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $2.011B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.839B | 0.00 |
| Freenome (FRNM) | United States | $1.838B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.735B | 66.25 |
| Alignment Healthcare (ALHC) | United States | $1.732B | 43.95 |
| Agilon Health (AGL) | United States | $1.497B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.490B | 0.00 |
| Ardent Health (ARDT) | United States | $1.478B | 8.45 |
| Nutex Health (NUTX) | United States | $1.430B | 8.20 |
| Omada Health (OMDA) | United States | $1.251B | 255.38 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.158B | 22.53 |
| Teladoc Health (TDOC) | United States | $1.145B | 0.00 |
| CryoPort (CYRX) | United States | $0.862B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.677B | 0.00 |
| Forward Industries (FWDI) | United States | $0.569B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| SBC Medicals (SBC) | United States | $0.489B | 10.11 |
| Strata Critical Medical (SRTA) | United States | $0.472B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.378B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.48 |
| Biodesix (BDSX) | United States | $0.308B | 0.00 |
| Embecta (EMBC) | United States | $0.300B | 2.59 |
| So-Young (SY) | China | $0.279B | 0.00 |
| LifeMD (LFMD) | United States | $0.155B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.101B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.097B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.082B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.073B | 8.67 |
| Tevogen (TVGN) | United States | $0.051B | 0.00 |
| DocGo (DCGO) | United States | $0.036B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |